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Asthma severityAbstract Background: It must be obvious that no one factor should be held accountable for the
etiology of allergic diseases, asthma or acute asthma exacerbations. Operating on a genetic basis
many factors must play a role. It has been postulated that vitamin D deﬁciency, as a result of
industrialization and Westernized lifestyles that have led to sun-avoidance behaviors and more time
indoors, has a role in the development of asthma and allergies (Green, 2010) [1].
Objective: To assess the relationship between serum vitamin D levels and severity of asthma in
patients with atopic asthma.
Patients and methods: The study was carried out on 30 patients with atopic asthma, divided into
three groups according to severity of airway obstruction, and ten healthy control subjects. Serum
25-hydroxyvitamin D3 [25(OH) D], a vitamin D metabolite, was measured using an immun-
odiagnostic ELISA technique.
Results: 86% of all asthmatic patients were vitamin D insufﬁcient, as deﬁned by a level 630 ng/
ml 25(OH) Vit D. Mean vitamin D levels were the lowest in patients with severe asthma.
Conclusion: Vitamin D insufﬁciency is common in patients with atopic asthma that is correlated
with its degree of severity.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Currently, the burden of asthma in both the developed and the
developing world is signiﬁcant and increasing rapidly with
more than 300 million people affected worldwide [1,2].Although it is well known that positive atopic status,
exposure and sensitization to environmental allergens and/or
familial history of allergic disease are signiﬁcant risk factors
associated with the development of asthma, recent evidence
suggests that vitamin D deﬁciency may also predispose to
allergic phenotype [3,4].
In vitro studies have demonstrated that vitamin D may play
an immune-modulatory role in human airway tissue through
innate, adaptive immune pathways [5,6]. The underlying
mechanisms of how vitamin D modulates the pathogenesis
of asthma are not clear. Vitamin D may modulate therculosis.
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cytes. Interestingly, the application of vitamin D is potentially
capable to overcome the poor glucocorticoid responsiveness in
severe asthmatics by upregulation of IL-10 production from
CD4+ T cells [7].
Prolonged breastfeeding without vitamin D supple-
mentation, maternal vitamin D deﬁciency, poor diet and lim-
ited sunshine exposure, liver and kidney diseases, poor food
absorption, use of certain medicines, including phenytoin,
phenobarbital, and rifampin have been suggested as major
contributors to vitamin D deﬁciency [8–10].
Aim of the study
The purpose of this study was to investigate serum Vit D levels
in patients with atopic asthma, detecting its correlation with
the degree of asthma severity.
Subjects and methods
This study was carried out on 30 patients with atopic asthma
divided into mild, moderate and severe asthma (groups; II,
III, and IV, respectively) admitted in the Chest Department,
Tanta University Hospital during the period from March
2013 to October 2013 and 10 nonsmokers, non-atopic healthy
volunteers was taken as a control group (group I).
Each subject received the regular routine of detailed
medical history, comprehensive physical examination and
appropriate laboratory tests including, skin prick tests (to
clarify atopic patients from non-atopics that will be excluded),
chest X-ray , lung function tests (to clarify severity), bron-
chodilator responsiveness (BDR; as deﬁned by an improve-
ment in the FEV1 of >200 ml and 12% after administration
of four puffs [0.1 mg/puff] salbutamol by metered dose inha-
ler), and BAL total cell and eosinophil count. Patients with
non-atopic asthma, signiﬁcant medical illness other than
asthma, a history of respiratory tract infection, or asthma
exacerbation within the previous 4 weeks were excluded.
Informed consent was obtained from all participants.
Blood collection and serum measurements of vitamin D
A collected venous blood sample was separated into serum and
stored at 70 C until analysis. Serum 25-hydroxyvitamin
D3 [25(OH) D], a vitamin D metabolite, was measured using
an immunodiagnostic ELISA commercially available kit
(Immundiagnostik AG, ALPCO, USA) for the quantitativeTable 1 Basic characteristics of study population.
Control group Mild a
Age 25.3 ± 4.6 36.5 ±
Sex (M/F) 6/4 7/3
FVC (% of pred) 99.5 ± 5.12 93.8 ±
FEV1 99.9 ± 5.54 89.6 ±
FEV1/FVC 101.3 ± 4.76 83.1 ±
PEFR 103.1 ± 5.86 94.1 ±
Skin t.  +
Total cell count · 103 157.3 ± 28.1 158.4 ±
Eosinophil % 0.49 ± 0.14 0.96 ±determination of the 25-OH-Vitamin D in serum according
to the manufacturer’s instructions. Vitamin D levels were cat-
egorized as deﬁcient if 25(OH) D was <20 ng/ml, insufﬁcient
if it was 20–29 ng/ml and sufﬁcient if it was >30 ng/ml [11].
Statistical analysis
Data were presented as mean ± standard deviation (X ± SD)
or percentage (%). The means of two groups were compared
using Student ‘‘t’’ test. Chi square (v2) was used to ﬁnd the
association between row and column variables. Linear correla-
tion and regression were used to test the correlation between
the measured parameters. Data were statistically analyzed with
the statistical package (SPPS), version 10 software. A p value
<0.05 was considered statistically signiﬁcant.
Results
Characteristics of our study population are illustrated in
Table 1.
Insufﬁcient serum Vit D was found in 70% of mild asth-
matics, 90% of moderate asthmatics and in all severe asthmat-
ics patients.
Serum Vit D levels [25(OH) D] were 65.4 ± 12.18,
29.1 ± 2.3, 26.3 ± 2.3, and 23.1 ± 1.3 ng/ml in groups I, II,
III, and VI, respectively. Serum Vit D was signiﬁcantly
decreased in patients with asthma compared to the healthy
subjects, with a signiﬁcant decrease in patients with severe
asthma compared to patients with mild and moderate asthma,
and non-signiﬁcant difference between mild and moderate and
between moderate and severe asthmatic patients (see Table 2).
There was a signiﬁcant positive correlation between serum
Vit D levels and FEV1 (% of pred), and signiﬁcant negative
correlation between serum Vit D levels and BAL eosinophils
% in patients with asthma with higher signiﬁcance in patients
with severe asthma, Figs. 1 and 2.
Discussion
Low levels of serum vitamin D are associated with impaired
pulmonary function, increased incidence of inﬂammatory
and infectious diseases. The exact mechanisms underlying
these data appear to have impact on the function of inﬂamma-
tory and structural cells, including dendritic cells, lymphocytes,
monocytes, and epithelial cells [12].
Searing et al. [13], found that serum vitamin D was
positively correlated with lung function and enhancedsthma Moderate asthma Severe asthma
5.9 34.4 ± 4.8 38.4 ± 5.4
5/5 8/2
6.84 90.2 ± 5.88 76.1 ± 10.72
4.24 71.1 ± 4.81 52.6 ± 5.08
7.90 71.4 ± 6.67 68.2 ± 7.91
6.52 73.4 ± 4.19 59.0 ± 5.35
+ +
32.3 176.9 ± 32.8 200.2 ± 35.3
0.36 1.26 ± 0.37 2.08 ± 0.53
Table 2 Serum Vit D levels (ng/ml) in the studied groups.
Control Mild asthma Moderate asthma Severe asthma
Vit D 65.4 ± 12.18 29.1 ± 2.3 26.3 ± 2.3 23.1 ± 1.3
T test Control and mild Control and moderate Control and severe Mild and moderate Mild and severe Moderate and severe
p 0.001 0.001 0.001 0.21 0.001 0.19
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Figure 1 Correlation between serum Vit D and FEV1 (% of
pred) in patients with asthma.
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Figure 2 Correlation between serum Vit D and BAL eosinophil
% in patients with asthma.
Serum vitamin D levels in patients with atopic asthma 305glucocorticoid action in peripheral blood mononuclear cells;
vitamin D was inversely correlated with total IgE, degree of
atopy, and use of inhaled or oral steroids.
Sutherland et al. [14], found that serum vitamin D was
positively correlated with FEV1 and glucocorticoid response;
vitamin D insufﬁciency or deﬁciency was associated with air-
way hyperresponsiveness.Another study showed a strong relationship between serum
concentrations of cholecalciferol, forced expiratory volume in
1 s (FEV1), and forced vital capacity, where decreasing pul-
monary function is associated with vitamin D deﬁciency [15].
Against our study ﬁndings, Devereux et al. [16], found no
signiﬁcant association between serum vitamin D levels and
asthma.Conclusion
We found that those asthmatics with low vitamin D levels did
worse on every measure; especially on pulmonary function
tests and also on inﬂammatory response, indicating vitamin
D may play a role in reducing inﬂammation. So, the results
of the study suggest the potential role of serum vitamin D
levels in asthmatic patients, affecting its degree of severity.
Also, the results suggest the potential importance of maintain-
ing adequate vitamin D levels in patients with atopic asthma,
that may help improve their asthma.
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